CES 2026 showcases next growth phase for Artificial Intelligence chips and devices

CES 2026 in Las Vegas highlights how Artificial Intelligence is shifting from experimental trials to mainstream consumer products, with major chipmakers and device makers emphasizing health, robotics, and new hardware. The event underlines a growing commercial focus that investors are watching for clues on future technology spending.

26 key trends shaping biotech and life sciences in 2026

Biotech and life sciences in 2026 are shifting from hype to execution, with Artificial Intelligence, gene editing, regulatory reform and global deal-making reshaping how therapies are discovered, developed and commercialized. The sector faces tighter policy, more selective capital and intensifying competition as new technologies and markets scale.